Skip to main content

Table 5 Responses to items measuring attitudes towards risk stratification (RS) for ovarian cancer (n = 146)

From: Health care professionals’ attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey

 

Strongly disagree N (%)

Disagree N (%)

Neither N (%)

Agree N (%)

Strongly agree N (%)

RS would help identify those most in need of screening for ovarian cancer.

1 (0.7)

7 (4.8)

7 (4.8)

115 (78.8)

16 (11.0)

RS would lead to ovarian cancer being missed in some patients.

0

9 (6.2)

20 (13.7)

112 (76.7)

5 (3.4)

RS would give patients a sense of control over their health.

0

5 (3.4)

48 (32.9)

88 (60.3)

5 (3.4)

RS for ovarian cancer would make patients feel fatalistic about their health

2 (1.4)

57 (39.0)

77 (52.7)

10 (6.8)

0

Stratification into low risk would give a false sense of security.

2 (1.4)

38 (26.0)

40 (27.4)

65 (44.5)

1 (0.7)

Stratification into a low risk group would be reassuring.

0

13 (8.9)

28 (19.2)

104 (71.2)

1 (0.7)

Stratification into a group at high risk would have a negative impact on well being

1 (0.7)

31 (21.2)

51 (34.9)

59 (40.4)

4 (2.7)

Stratification into a group at intermediate risk would have a negative impact on well being

2 (1.4)

28 (19.2)

66 (45.2)

49 (33.6)

1 (0.7)

Stratification into a group at low risk would have a negative impact on well being

9 (6.2)

104 (71.2)

29 (19.9)

4 (2.7)

0

Risk stratification consultation (communication) self-efficacy.

     

I am confident I could explain what ‘low risk’ means to patients in that group

0

7 (4.8)

10 (6.8)

97 (66.4)

32 (21.9)

I am confident I could explain what ‘intermediate risk’ means to patients in that group

0

9 (6.2)

15 (10.3)

93 (63.7)

29 (19.9)

I am confident I could explain what ‘high risk’ means to patients in that group

0

6 (4.1)

12 (8.2)

94 (64.4)

34 (23.3)